Thomas Abraham

Title: Thomas Abraham: Innovator in TRPV3 Modulation

Introduction

Thomas Abraham is a notable inventor based in Navi Mumbai, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate transient receptor potential vanilloid (TRPV) channels. His work is essential for advancing treatments for various diseases and conditions.

Latest Patents

Thomas holds a patent for "Fused imidazole carboxamides as TRPV3 modulators." This invention provides novel TRPV modulators of formula (I). The compounds described in this patent are particularly useful for treating or preventing diseases, conditions, and disorders modulated by TRPV3. The patent also outlines processes for preparing these compounds, intermediates used in their synthesis, pharmaceutical compositions, and methods for treating or preventing related diseases.

Career Highlights

Thomas Abraham is currently associated with Glenmark Pharmaceuticals S.A., where he applies his expertise in drug development. His innovative approach has led to advancements in the pharmaceutical industry, particularly in the area of TRPV3 modulation.

Collaborations

Some of his notable coworkers include Sachin Sundarlal Chaudhari and Ashok Bhausaheb Kadam. Their collaborative efforts contribute to the success of projects at Glenmark Pharmaceuticals.

Conclusion

Thomas Abraham is a distinguished inventor whose work in TRPV3 modulation has the potential to impact the treatment of various medical conditions. His contributions to the pharmaceutical field are invaluable and highlight the importance of innovation in healthcare.